Back to the search results

Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721-93-0
Fax: 07721-93-98001
Mail: ed.sv-kbs@mukinilkofni

http://www.sbk-vs.de

Basic information

Number of beds: 845
Number of specialist departments: 20

Number of inpatient cases: 37.824
Number of outpatient cases: 120.871

Hospital owners: Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH
Type of provider: öffentlich

Specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	yes
Bezeichnung
Teilnahme externe Qualitätssicherung	yes
Bezeichnung
Teilnahme externe Qualitätssicherung	yes

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Implementation of the minimum quantity agreement

Treatment area

Knee joint total endoprostheses

Quantity performed	41
Exception?	No exception

Complex interventions on the organ system esophagus for adults

Quantity performed	12
Exception?	No exception

Quantity performed	40
Exception?	No exception

Stem cell transplant

Quantity performed	36
Exception?	No exception

Quantity performed	37
Exception?	No exception

Minimum quantities forecast

Knee joint total endoprostheses

Overall result forecast presentation:	Pending lawsuit
Quantity performed reporting year:	41
Quantity forecast year:	58
Examination by state associations?	Pending lawsuit
Exemption?	yes
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Complex interventions on the organ system esophagus for adults

Overall result forecast presentation:	yes
Quantity performed reporting year:	12
Quantity forecast year:	20
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Overall result forecast presentation:	yes
Quantity performed reporting year:	40
Quantity forecast year:	85
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Stem cell transplant

Overall result forecast presentation:	yes
Quantity performed reporting year:	36
Quantity forecast year:	59
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Overall result forecast presentation:	yes
Quantity performed reporting year:	37
Quantity forecast year:	68
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ25	Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ24	Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022)
CQ05	Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ01	Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: yes

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
251	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
163	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
103	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
Commentary on the protection concept: Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children

Use of standardised forms for drug medical history

Verfahrens- und Arbeitsanweisung, SOP

15.12.2021

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Verfahrens- und Arbeitsanweisung, SOP

15.12.2021

SOP on good prescription practices

Verfahrens- und Arbeitsanweisung, SOP

15.12.2021

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
Versorgung der Patientinnen und Patienten mit patientenindividuell abgepackten Arzneimitteln durch die Krankenhausapotheke (z.B. Unit-Dose-System)

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

HB07 - Surgical technical assistant (m/f)

Comment

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 11
- Additional staff: 12
- Nursing staff regulation

Service contact persons

Patient advocates

Renate Bohrer

Patientenfürsprecherin

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4381
Mail: ed.sv-kbs@rerhob.etaner

Bernd Bierer

Patientenfürsprecher

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4380
Mail: ed.sv-kbs@rereib.dnreb

Isolde Weißhaar

Patientenfürsprecherin

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4382
Mail: ed.sv-kbs@raahssiew.edlosi

Karl-Heinz Hahn

Patientenfürsprecher

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 0771 -88-5662
Mail: ed.sv-kbs@nhah.znieh-lrak

Irmgard Stern

Patientenfürsprecherin

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4383
Mail: ed.sv-kbs@nrets.dragmri

Gerd Vosseler

Patientenfürsprecher

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 0771 -88-5662
Mail: ed.sv-kbs@relessov.dreg

Renate Bohrer

Patientenfürsprecherin

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4381
Mail: ed.sv-kbs@rerhob.etaner

Susanne Dieckmann

Patientenfürsprecherin

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4380
Mail: ed.sv-kbs@nnamkeid.ennasus

Isolde Weißhaar

Patientenfürsprecherin

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4382
Mail: ed.sv-kbs@raahssiew.edlosi

Gerd Vosseler

Patientenfürsprecher

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 0771 -88-5662
Mail: ed.sv-kbs@relessov.dreg

Irmgard Stern

Patientenfürsprecherin

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4383
Mail: ed.sv-kbs@nrets.dragmri

Thomas Schlenker

Patientenfürsprecher

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-4380
Mail: ed.sv-kbs@reknelnhcs.samoht

Customer feedback management

Dr. Simon Steiff

Medizinischer Direktor

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8300
Mail: ed.sv-kbs@ffiets.nomis

Dr. Simon Steiff

Medizinischer Direktor

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8300
Mail: ed.sv-kbs@ffiets.nomis

Quality management

Klaus Kugel

Abteilungsleitung Qualitätsmanagement

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8350
Mail: ed.sv-kbs@leguk.sualk

Klaus Kugel

Abteilungsleitung Qualitätsmanagement

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8350
Mail: ed.sv-kbs@leguk.sualk

Hygiene officer

PD Dr. med. Matthias Henschen

Ärztlicher Direktor

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-3200
Mail: ed.sv-kbs@nehcsneh.saihttam

PD Dr. med. Matthias Henschen

Ärztlicher Direktor

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-3200
Mail: ed.sv-kbs@nehcsneh.saihttam

Responsible for drug therapy

Dr. rer. nat. Matthias Fellhauer

Direktor der Apotheke

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-3901
Mail: ed.sv-kbs@reuahllef.saihttam

Moritz Vitt

Direktor der Apotheke

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-3901
Mail: ed.sv-kbs@ttiV.ztiroM

Accessibility Officer

Dipl. Sozialpädagogin Brigitte Langlois

Mitarbeiterin Sozialdienst

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8367
Mail: ed.sv-kbs@siolgnal.ettigirb

Dipl. Sozialpädagogin Brigitte Langlois

Mitarbeiterin Sozialdienst

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8457
Mail: ed.sv-kbs@siolgnal.ettigirb

Company

General contact details of the hospital

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721-93-0
Fax: 07721-93-98001
Mail: ed.sv-kbs@mukinilkofni

Nursing service management

Arne Holthuis

Leitender Pflegedirektor

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-1700
Mail: ed.sv-kbs@siuhtloh.enra

Arne Holthuis

Leitender Pflegedirektor

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-1700
Mail: ed.sv-kbs@siuhtloh.enra

Head of administration

Dr. Matthias Geiser

Geschäftsführer

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8001
Mail: ed.sv-kbs@resieg.saihttam

Dr. Matthias Geiser

Geschäftsführer

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8001
Mail: ed.sv-kbs@resieg.saihttam

Responsible for the quality report in the hospital management

Dr. Matthias Geiser

Geschäftsführer

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8001
Mail: ed.sv-kbs@resieg.saihttam

Dr. Matthias Geiser

Geschäftsführer

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-8001
Mail: ed.sv-kbs@resieg.saihttam

Medical management

PD Dr. med. Matthias Henschen

Ärztlicher Direktor

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-3200
Mail: ed.sv-kbs@nehcsneh.saihttam

PD Dr. med. Matthias Henschen

Ärztlicher Direktor

Klinikstraße 11
78052 Villingen-Schwenningen

Phone: 07721 -93-3200
Mail: ed.sv-kbs@nehcsneh.saihttam

Regional care obligation for psychiatry?

IK number

IK: 260831312

Location number

Location number: 773574000

Old location number: 773574000

Hospital portrait for download